We recently reported that suppression of AR activity in human dermal fibroblasts (HDFs) by a ligand-competitive inhibitor induces expression of a battery of tumor-promoting cancer-associated fibroblast effector genes, similarly to silencing of the gene (Clocchiatti et al., 2018). This evidence concerns the gene AR and neoplasm.